Johnson & Johnson and a subsidiary have to pay for the way it marketed antipsychotic drug Risperdal, neglecting to mention its side effects while claiming it was safer and worked better than the competition. In Arkansas, one of 11 states in which J&J has faced legal battles over the drug, a judge ordered the company to pay $1.2 billion to make up for its alleged sins.

Hey people with Medicare, you’re about to become a little more attractive to scammers. That’s because this week the government will start sending out its one-time tax free rebate checks to those of you who have already hit the donut hole gap in your Medicare coverage. The main thing to know, advises Medicare, is that you don’t need to provide any information to anyone to get the rebate–it’s automatic.